Please login to the form below

Not currently logged in
Email:
Password:

Barry Labinger joins Biothera Pharmaceutical

Brings experience from Human Genome Sciences and 3M Pharmaceuticals
Biothera Pharmaceutical Barry Labinger

US biotech company Biothera Pharmaceutical has appointed Barry Labinger as its new chief executive officer.

Labinger has nearly three decades of pharmaceutical and biotech industry experience, with roles at Emergent BioSolutions, Human Genome Sciences, 3M Pharmaceuticals and Immunex.

His experience with oncology drug development will be particularly useful to the Minnesota-based firm, which is developing a novel cancer immunotherapy.

Richard Mueller, chairman of the board at Biothera Holding Corp, said: “Barry has strong leadership and management skills to take Biothera Pharmaceutical forward and realise the full potential of Imprime PGG, the company's first-in-class immune modulator, which we believe is the next step in immune oncology.

“We are delighted to have such an accomplished executive lead the company through the next phase of its development.”

Labinger most recently served as executive vice president and president, Biosciences Division, at Emergent BioSolutions Inc., where he was responsible for all aspects of product development, manufacturing, and commercialisation.

14th December 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...